WallStreetZenWallStreetZen

NASDAQ: NVAX
Novavax Inc Stock Forecast, Predictions & Price Target

Analyst price target for NVAX

Based on 3 analysts offering 12 month price targets for Novavax Inc.
Min Forecast
$10.00-23.14%
Avg Forecast
$13.67+5.05%
Max Forecast
$19.00+46.04%

Should I buy or sell NVAX stock?

Based on 3 analysts offering ratings for Novavax Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NVAX stock forecasts and price targets.

NVAX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-13Find Out Why
lockedlocked$00.00+00.00%2024-05-13
lockedlocked$00.00+00.00%2024-05-10Find Out Why

1 of 1

Forecast return on equity

Is NVAX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.39%

Forecast return on assets

Is NVAX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NVAX revenue forecast

What is NVAX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$919.6M-7.73%
Avg 2 year Forecast
$686.2M-31.15%
Avg 3 year Forecast
$637.5M-36.03%
NVAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NVAX revenue growth forecast

How is NVAX forecast to perform vs Biotechnology companies and vs the US market?
Company
-13.84%
Industry
37.19%
Market
9.95%
NVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NVAX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NVAX$13.01$13.67+5.05%Hold
ARDX$7.81$14.60+86.94%Strong Buy
FUSN$21.51$20.25-5.86%Hold
INBX$34.70$27.00-22.19%Buy
NAMS$20.09$33.25+65.51%Strong Buy

Novavax Stock Forecast FAQ

Is Novavax Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: NVAX) stock is to Hold NVAX stock.

Out of 3 analysts, 0 (0%) are recommending NVAX as a Strong Buy, 1 (33.33%) are recommending NVAX as a Buy, 2 (66.67%) are recommending NVAX as a Hold, 0 (0%) are recommending NVAX as a Sell, and 0 (0%) are recommending NVAX as a Strong Sell.

If you're new to stock investing, here's how to buy Novavax stock.

What is NVAX's revenue growth forecast for 2024-2026?

(NASDAQ: NVAX) Novavax's forecast annual revenue growth rate of -13.84% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Novavax's revenue in 2024 is $996,609,000.On average, 2 Wall Street analysts forecast NVAX's revenue for 2024 to be $129,116,512,294, with the lowest NVAX revenue forecast at $113,743,727,166, and the highest NVAX revenue forecast at $144,489,297,421. On average, 5 Wall Street analysts forecast NVAX's revenue for 2025 to be $96,341,549,070, with the lowest NVAX revenue forecast at $6,982,268,740, and the highest NVAX revenue forecast at $168,470,224,445.

In 2026, NVAX is forecast to generate $89,507,967,693 in revenue, with the lowest revenue forecast at $3,990,269,005 and the highest revenue forecast at $142,832,535,484.

What is NVAX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NVAX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NVAX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year NVAX price target, the average NVAX price target is $13.67, with the highest NVAX stock price forecast at $19.00 and the lowest NVAX stock price forecast at $10.00.

On average, Wall Street analysts predict that Novavax's share price could reach $13.67 by May 13, 2025. The average Novavax stock price prediction forecasts a potential upside of 5.05% from the current NVAX share price of $13.01.

What is NVAX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NVAX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.